Zacks.com on MSN

Amgen's Q3 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up

AMGN's Q3 earnings and revenues top estimates as key drugs drive double-digit growth. The company also raises its 2025 outlook.

StrategX Announces Positive Drill Results Confirming Expansion of Large-Scale Critical ...

Drill Intersection Returns 49.9 metre polymetallic interval grading 0.26% Ni,0.11% Cu, 0.18% V2O5, and 6.92 g/t Ag 580 metres ...